Aligos Therapeutics's market cap is currently $74.81M. The company's EPS TTM is $-13.346; its P/E ratio is ―; Aligos Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-2.50. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 15.53M	$ 13.91M	$ 4.36M	$ 0.00	$ 0.00
Gross Profit	$ 12.46M	$ 10.23M	$ -99.79M	$ -3.33M	$ -2.30M
Operating Income	$ -88.13M	$ -97.58M	$ -128.32M	$ -97.83M	$ -54.04M
EBITDA	$ -85.06M	$ -93.91M	$ -124.54M	$ -105.06M	$ -49.88M
Net Income	$ -87.68M	$ -96.05M	$ -128.33M	$ -108.54M	$ -52.26M
Balance Sheet
Cash & Short-Term Investments	$ 135.70M	$ 125.83M	$ 190.73M	$ 243.51M	$ 117.66M
Total Assets	$ 151.53M	$ 146.69M	$ 235.37M	$ 265.30M	$ 146.52M
Total Debt	$ 11.14M	$ 12.57M	$ 14.46M	$ 13.01M	$ 14.33M
Net Debt	$ -124.57M	$ -68.77M	$ -172.36M	$ -207.38M	$ -55.23M
Total Liabilities	$ 59.45M	$ 42.79M	$ 50.64M	$ 45.26M	$ 211.41M
Stockholders' Equity	$ 92.08M	$ 103.90M	$ 184.73M	$ 220.04M	$ -64.89M
Cash Flow
Free Cash Flow	$ -79.02M	$ -80.33M	$ -116.55M	$ -76.33M	$ -49.55M
Operating Cash Flow	$ -79.00M	$ -79.39M	$ -115.66M	$ -74.26M	$ -46.77M
Investing Cash Flow	$ 44.98M	$ -26.29M	$ 3.02M	$ 32.76M	$ 6.79M
Financing Cash Flow	$ 88.33M	$ 164.00K	$ 78.68M	$ 192.35M	$ 85.53M

Currency in USD

Aligos Therapeutics Earnings and Revenue History

Income Statement >

Aligos Therapeutics Debt to Assets

Balance Sheet >

Aligos Therapeutics Cash Flow

Cash Flow >

Aligos Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing